Information on the supply cessation of the Croatian market with the medicinal product Garasone eye/ear drops(gentamicin, betamethasone)
03.08.2012
Merck Sharp & Dohme d.o.o., the marketing authorisation holder for the medicinal product Garasone eye/ear drops (gentamicin, betamethasone) has informed the Agency for Medicinal Products and Medical Devices about the supply cessation of the croatian market with the aforementioned product.
The supply cessation of the Croatian market with the aforementioned product is caused by a decision of the manufacturer Schering-Plough N.V., Heist-op-den-Berg, Belgium on the cessation of the manufacturing and distribution of the product at the global level, for commercial reasons, due to the unsustainability of the manufacturing process.
